REGULATED PRESS RELEASE published on 02/25/2026 at 07:00, 6 months 14 days ago 2025 results. Solid performance in an unstable environment. Operating margin: 19.5% - Net margin: 14.1% - Dividend per share: €1.05 Interparfums reports solid performance in 2025 despite external challenges, maintaining high margins. Financial results show stable operating and net margins Financial Performance Interparfums Operating Margin Net Margin 2025 Results
REGULATED PRESS RELEASE published on 02/25/2026 at 06:59, 6 months 14 days ago OPmobility - 2025 Annual Results and Governance OPmobility reports strong 2025 full-year results with operating margin up +11.4% to €490 million, EBITDAe) up +7.7% to €1,001 million, and net debt reduced by -€167 million. Félicie Burelle confirmed as CEO, diversification strategy confirmed in North America and Asia Operating Margin Diversification Strategy OPmobility Félicie Burelle 2025 Full-year Results
REGULATED PRESS RELEASE published on 02/25/2026 at 06:59, 6 months 14 days ago OPmobility - Résultats annuels 2025 et Gouvernance
PRESS RELEASE published on 02/25/2026 at 06:45, 6 months 14 days ago #FutureFresenius: REJUVENATE in action – Delivering accelerated performance for long-term value creation; 2025 yet another year of strong delivery Fresenius SE & Co. KGaA reports strong FY/25 results with 7% organic revenue growth and 12% Core EPS growth. Improved EBIT margin and increased dividend proposal. #FutureFresenius strategy aims for sustainable growth Financial Results Organic Revenue Growth Fresenius Core EPS #FutureFresenius
PRESS RELEASE published on 02/25/2026 at 06:30, 6 months 14 days ago Formycon announces positive clinical data for Keytruda® biosimilar candidate FYB206 (pembrolizumab) Formycon announces positive clinical data for Keytruda biosimilar candidate FYB206 (pembrolizumab), confirming pharmacokinetic equivalence with Keytruda Clinical Data Biosimilar Formycon Keytruda Pembrolizumab
PRESS RELEASE published on 02/25/2026 at 06:00, 6 months 14 days ago Fresenius Supervisory Board extends ahead of schedule CEO Michael Sen’s contract by five years --- Christian Pawlu to join Management Board for Fresenius Helios effective July 1, 2026 Fresenius extends CEO Michael Sen's contract by 5 years and appoints Christian Pawlu to Management Board effective July 1, 2026, ensuring continuity and strategic leadership for #FutureFresenius. Dr. Pawlu to oversee Fresenius Helios operations replacing Robert Möller Contract Extension Management Board CEO Fresenius Christian Pawlu
PRESS RELEASE published on 02/25/2026 at 01:10, 6 months 14 days ago Northfield Announces Intention to Commence Normal Course Issuer Bid Northfield Capital Corporation announces normal course issuer bid to purchase up to 1,035,239 Class A restricted voting shares on TSXV. The bid aims to capitalize on undervalued shares TSX Venture Exchange Normal Course Issuer Bid Class A Shares Undervalued Northfield Capital Corporation
PRESS RELEASE published on 02/25/2026 at 00:50, 6 months 14 days ago Pew Applauds Milestone Ratification of International Treaty to Improve Safety at Sea The Pew Charitable Trusts welcomes the ratification of the Cape Town Agreement to enhance safety at sea, protect fishers, and combat IUU fishing, marking a significant step towards sustainable ocean governance IUU Fishing Cape Town Agreement Pew Charitable Trusts Safety At Sea Sustainable Ocean Governance
PRESS RELEASE published on 02/25/2026 at 00:00, 6 months 14 days ago Nepra Foods Announces Closing of Debt Conversion Nepra Foods Inc. announces debt conversion transaction with Lender William Hogan, issues Common Shares. Shares subject to statutory hold period. Details on US securities laws compliance provided Common Shares Nepra Foods Inc. Debt Conversion Transaction Statutory Hold Period US Securities Laws
PRESS RELEASE published on 02/24/2026 at 22:45, 6 months 14 days ago 2CRSi SA: Après la qualification réussie du fluide, Chemours et 2CRSi s’associent pour accélérer l’adoption du refroidissement liquide biphasé dans les serveurs haute densité. Chemours et 2CRSi s'associent pour accélérer l'adoption du refroidissement liquide biphasé dans les serveurs haute densité et les infrastructures informatiques Innovation Technologique 2CRSi Serveurs Haute Densité Chemours Refroidissement Liquide Biphasé
Published on 09/10/2026 at 22:25, 10 hours 35 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 17 hours 40 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 08:15, 45 minutes ago EQS-Adhoc: Airbus SE: Airbus commences limited share buyback to support future employee share ownership plan activities and equity-based compensation
Published on 09/11/2026 at 08:02, 58 minutes ago PUMA CCO Matthias Baeumer to step down from Management Board
Published on 09/11/2026 at 07:30, 1 hour 30 minutes ago NAGRAVISION and MediaTek Broaden Partnership to Redefine Content Security for Premium Content on Connected TVs
Published on 09/11/2026 at 00:05, 8 hours 55 minutes ago Club Offers for Travel Enthusiasts in Germany
Published on 09/11/2026 at 07:00, 2 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 13 hours 30 minutes ago Availability of the 2026 Interim Financial Report